Patients Eligible to a Curative Treatment for Primary HCC

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Patients Eligible to a Curative Treatment for Primary HCC trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT02824185

Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) in Curative Treatment o…

Hepatocellular carcinoma (HCC) is the fifth most common cancer in terms of incidence and the second in terms of mortality. At an early stage, which is based on…

France61 participantsStarted 2017-06-14

Treatment: PET/MRI system (SIEMENS AG, Munich, Germany; distributed in France by SIEMENS S.A.S, Saint-Denis, France)